Clinical trial
Dienogest Versus a Low-dose Combined Oral Contraceptive for Treatment of Adenomyotic Uteri
NCT03890042 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dienogest Versus a Low-dose Combined Oral Contraceptive for Treatment of Adenomyotic Uteri
- Lead sponsor
- Assiut University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2019
- Completion date
- August 1, 2020
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.